IGM Biosciences, Inc. Quarterly Liabilities, Current in USD from Q4 2018 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: IGM Biosciences, Inc. quarterly Liabilities, Current history and growth rate from Q4 2018 to Q3 2024.
IGM Biosciences, Inc. Liabilities, Current for the quarter ending September 30, 2024 was $44M, a 2.33% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$44M	+$999K	+2.33%	Sep 30, 2024	10-Q	2024-11-08
Q2 2024	$37.7M	-$6.64M	-15%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$37.9M	-$5.7M	-13.1%	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$42.5M	-$2.2M	-4.93%	Dec 31, 2023	10-Q	2024-11-08
Q3 2023	$43M	-$1.52M	-3.42%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$44.3M	+$8.48M	+23.7%	Jun 30, 2023	10-Q	2023-08-03
Q1 2023	$43.6M	+$16.3M	+59.4%	Mar 31, 2023	10-Q	2023-05-12
Q4 2022	$44.7M	+$16.9M	+60.9%	Dec 31, 2022	10-K	2024-03-07
Q3 2022	$44.5M	+$24M	+118%	Sep 30, 2022	10-Q	2022-11-03
Q2 2022	$35.8M	+$16.8M	+87.9%	Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$27.4M	+$12.6M	+84.7%	Mar 31, 2022	10-Q	2022-05-09
Q4 2021	$27.8M	+$10.5M	+61.1%	Dec 31, 2021	10-K	2023-03-30
Q3 2021	$20.5M	+$7.17M	+54%	Sep 30, 2021	10-Q	2021-11-04
Q2 2021	$19.1M	+$7.89M	+70.6%	Jun 30, 2021	10-Q	2021-08-09
Q1 2021	$14.8M	+$7.27M	+96.4%	Mar 31, 2021	10-Q	2021-05-06
Q4 2020	$17.2M	+$8.37M	+94.3%	Dec 31, 2020	10-K	2022-03-29
Q3 2020	$13.3M	+$6.86M	+107%	Sep 30, 2020	10-Q	2020-11-05
Q2 2020	$11.2M			Jun 30, 2020	10-Q	2020-08-06
Q1 2020	$7.54M			Mar 31, 2020	10-Q	2020-05-07
Q4 2019	$8.88M	-$15K	-0.17%	Dec 31, 2019	10-K	2021-03-30
Q3 2019	$6.42M			Sep 30, 2019	10-Q	2019-11-07
Q4 2018	$8.89M			Dec 31, 2018	10-K	2020-03-26

* An asterisk sign (*) next to the value indicates that the value is likely invalid.